SCHEMBL22612677

SCHEMBL22612677

CCCCCCCCCC(O)CC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 4/20 0.71
▸ MAPT P10636 4/20 0.71
▸ LMNA P02545 4/20 0.71
▸ CYP1A2 P05177 3/20 0.71
▸ GMNN O75496 3/20 0.71
▸ NPSR1 Q6W5P4 3/20 0.71
▸ MEN1 O00255 3/20 0.71
▸ KMT2A Q03164 3/20 0.71
▸ TP53 P04637 3/20 0.71
▸ TSHR P16473 3/20 0.71
▸ HSP90AA1 P07900 2/20 0.71
▸ BLM P54132 2/20 0.71
▸ NR1H4 Q96RI1 2/20 0.71
▸ CYP2C9 P11712 2/20 0.71
▸ HIF1A Q16665 2/20 0.71
▸ GLA P06280 1/20 0.69
▸ PMP22 Q01453 1/20 0.69
▸ GPR84 Q9NQS5 4/20 0.58
▸ SLC25A20 O43772 3/20 0.54
▸ CYP2D6 P10635 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28400574 1.00 MAPK1 (0.71) MAPK1MAPTLMNACYP1A2GMNN
SCHEMBL28715063 1.00 MAPK1 (0.71) MAPK1MAPTLMNACYP1A2GMNN
SCHEMBL27768116 1.00 MAPK1 (0.71) MAPK1MAPTLMNACYP1A2GMNN
SCHEMBL28466494 1.00 MAPK1 (0.71) MAPK1MAPTLMNACYP1A2GMNN
SCHEMBL22635967 1.00 MAPK1 (0.71) MAPK1MAPTLMNACYP1A2GMNN
SCHEMBL25194019 1.00 MAPK1 (0.71) MAPK1MAPTLMNACYP1A2GMNN
Hydrochloric Acid SCHEMBL28715044 0.99 MAPK1 (0.69) MAPK1MAPTLMNACYP1A2GMNN
SCHEMBL25186738 0.99 CYP1A2 (0.70) MAPK1MAPTLMNACYP1A2GMNN
SCHEMBL22392373 0.89 CYP1A2 (0.62) MAPK1MAPTLMNACYP1A2GMNN
SCHEMBL17891419 0.88 MEN1 (0.71) MAPK1MAPTLMNACYP1A2GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118033023-A Lung cancer biomarker and application thereof 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 2024-05-14 — — CN claimed
US-20230194554-A1 USE OF BIOMARKER IN PREPARATION OF LUNG CANCER DETECTION REAGENT AND RELATED METHOD SUN YAT-SEN UNIVERSITY CANCER CENTER (THE AFFILIATED CANCER HOSPITAL OF SUN YAT-SEN UNIVERSITY, THE CANCER RESEARCH INSTITUTE OF SUN YAT-SEN UNIVERSITY) (CN) 2023-06-22 — — US claimed
CN-113960235-A Application and method of biomarker in preparation of lung cancer detection reagent 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 2022-01-21 — — CN claimed
US-20250295713-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2025-09-25 — — US disclosed
US-12064459-B2 Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes DERMBIONT, INC. (US) 2024-08-20 — — US disclosed
CN-118033023-A Lung cancer biomarker and application thereof 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 2024-05-14 — — CN disclosed
US-20230194554-A1 USE OF BIOMARKER IN PREPARATION OF LUNG CANCER DETECTION REAGENT AND RELATED METHOD SUN YAT-SEN UNIVERSITY CANCER CENTER (THE AFFILIATED CANCER HOSPITAL OF SUN YAT-SEN UNIVERSITY, THE CANCER RESEARCH INSTITUTE OF SUN YAT-SEN UNIVERSITY) (CN) 2023-06-22 — — US disclosed
US-20220160617-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2022-05-26 — — US disclosed
CN-113960235-A Application and method of biomarker in preparation of lung cancer detection reagent 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 2022-01-21 — — CN disclosed
US-20210386802-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2021-12-16 — — US disclosed
US-20210361725-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2021-11-25 — — US disclosed
US-11040077-B2 Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes DERMBIONT, INC. (US) 2021-06-22 — — US disclosed
US-20200345799-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2020-11-05 — — US disclosed
Send feedback